Skip to content

VBI VACCINES INC.

CIK 0000704159

← back to feed
Revenue (TTM)
$4.35M
−96.3% YoY FY Feb 2016
Net Income (TTM)
−$16.29M
+3.6% YoY FY Feb 2016
EPS Diluted (TTM)
−$2.06
FY Feb 2016
Gross Margin
—
FY Feb 2016
Operating Margin
-355.2%
FY Feb 2016
Net Margin
-374.7%
FY Feb 2016
Free Cash Flow (TTM)
−$2.6M
FY Feb 2016
Cash
$7.28M
FY Feb 2016
Total Debt
$1.99M
FY Feb 2016
Shares Outstanding
25.5M sh
FY Feb 2016

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings